Future research should focus on investigating the correlation between tear LT-α levels and other tear fluid biomarkers in keratoconus patients, evaluating tear protein markers in individuals with varying LT-α expression levels, and analyzing the relationship between these markers and clinical manifestations of keratoconus, including corneal topographic findings. This evidence concerns the gene LTA and keratoconus.